AQR Capital Management’s Organogenesis Holdings ORGO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.62M | Sell |
717,072
-176,695
| -20% | -$647K | ﹤0.01% | 1622 |
|
|
2025
Q1 | $3.86M | Sell |
893,767
-628,387
| -41% | -$2.71M | ﹤0.01% | 1258 |
|
|
2024
Q4 | $4.87M | Sell |
1,522,154
-1,188,452
| -44% | -$3.8M | 0.01% | 1112 |
|
|
2024
Q3 | $7.75M | Buy |
2,710,606
+441,846
| +19% | +$1.26M | 0.01% | 885 |
|
|
2024
Q2 | $6.35M | Buy |
2,268,760
+986,132
| +77% | +$2.76M | 0.01% | 922 |
|
|
2024
Q1 | $3.64M | Buy |
1,282,628
+91,635
| +8% | +$260K | 0.01% | 1126 |
|
|
2023
Q4 | $4.87M | Sell |
1,190,993
-351,767
| -23% | -$1.44M | 0.01% | 964 |
|
|
2023
Q3 | $4.91M | Sell |
1,542,760
-133,173
| -8% | -$423K | 0.01% | 935 |
|
|
2023
Q2 | $5.56M | Sell |
1,675,933
-876,280
| -34% | -$2.91M | 0.01% | 861 |
|
|
2023
Q1 | $5.44M | Buy |
2,552,213
+361,648
| +17% | +$770K | 0.01% | 852 |
|
|
2022
Q4 | $5.89M | Buy |
2,190,565
+902,291
| +70% | +$2.43M | 0.01% | 821 |
|
|
2022
Q3 | $4.17M | Buy |
1,288,274
+943,251
| +273% | +$3.06M | 0.01% | 896 |
|
|
2022
Q2 | $1.68M | Buy |
345,023
+188,963
| +121% | +$922K | ﹤0.01% | 1186 |
|
|
2022
Q1 | $1.19M | Sell |
156,060
-39,087
| -20% | -$298K | ﹤0.01% | 1450 |
|
|
2021
Q4 | $1.8M | Buy |
195,147
+116,971
| +150% | +$1.08M | ﹤0.01% | 1234 |
|
|
2021
Q3 | $1.11M | Sell |
78,176
-2,422
| -3% | -$34.5K | ﹤0.01% | 1478 |
|
|
2021
Q2 | $1.34M | Buy |
80,598
+64,711
| +407% | +$1.08M | ﹤0.01% | 1441 |
|
|
2021
Q1 | $289K | Buy |
+15,887
| New | +$289K | ﹤0.01% | 2020 |
|